Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
5,010,694
-
Share change
-
-772,055
-
Total reported value
-
$39,581,498
-
Price per share
-
$7.90
-
Number of holders
-
37
-
Value change
-
-$9,127,813
-
Number of buys
-
21
-
Number of sells
-
24
Institutional Holders of EIGER BIOPHARMACEUTICALS INC - COM (EIGR) as of Q2 2017
As of 30 Jun 2017 EIGER BIOPHARMACEUTICALS INC - COM (EIGR) had 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 5,010,694 shares of stock of the company.
Largest 10 holders included Vivo Capital, LLC, InterWest Venture Management Co, SPHERA FUNDS MANAGEMENT LTD., SABBY MANAGEMENT, LLC, PERCEPTIVE ADVISORS LLC, Boxer Capital, LLC, VANGUARD GROUP INC, Lombard Odier Asset Management (USA) Corp, BRIDGEWAY CAPITAL MANAGEMENT INC, and Hikari Power Ltd.
This table shows 37 institutional shareholders of the security as of 30 Jun 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.